Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve

Astarci, Parla; Glineur, David; Kefer, Joelle; D’Hoore, William; Renkin, Jean; Vanoverschelde, Jean-Louis; El Khoury, Gébrine; Grandin, Cécile
August 2011
European Journal of Cardio-Thoracic Surgery;Aug2011, Vol. 40 Issue 2, p475
Academic Journal
Abstract: Objective: Cerebral embolization during trans-catheter aortic valve implantation (TAVI) has not been assessed clearly in the literature. Therefore, we compared the rate of cerebral embolisms with diffusion-weighted magnetic resonance imaging (DWI) in transfemoral (TF) and trans-apical (TA) approaches. Method: Eighty patients benefited from TAVI between January 2008 and June 2010. Out of these, 35 were included in the study. Twenty-one were TF (group 1) and 14 TA (group 2). During the same period, 285 patients benefited from a conventional aortic valve surgery (aortic valve replacement (AVR)). Thirteen of these were also analyzed and considered as the control group (group 3). We systematically performed a DWI the day before the procedure and 48h after. DWI studies were blindly analyzed by a neuroradiologist, and all patients had a clinical neurological assessment before and after the procedure, according the National Institutes of Health Stroke Scale (NIHSS). Results: Thirty-two patients in the TAVI group had new cerebral lesions: 19 in the TF group and 13 in the trans-apical group (p =NS). Mean number of embolic lesions per patient was 6.6 in group I and 6.0 in group II (p =NS). Mean volume of embolic lesions was 475.0mm3 in group I and 2170.5mm3 in group II (p =NS). In group III, one patient had one new cerebral lesion (p <0.05 vs TAVI) of 36.5mm3 (p =NS vs TAVI). All patients were neurologically asymptomatic. Conclusions: The incidence of silent cerebral embolic lesions after TAVI is significantly higher compared with the standard surgical AVR. The number of emboli is similar in the TF and TA groups but the volume tended to be higher in the TA group. However, there is no clinical impact of those lesions.


Related Articles

  • Transcatheter aortic valve implantation: the evidence. Sinning, Jan-Malte; Werner, Nikos; Nickenig, Georg; Grube, Eberhard // Heart;Nov 2012 Supplement, Vol. 98, piv65 

    Transcatheter aortic valve implantation (TAVI) is the new standard-of-care for inoperable patients with better outcome than conservative management, including balloon valvuloplasty only. In high-risk patients, TAVI has clearly shown non-inferiority compared with surgical aortic valve...

  • Transapical transcatheter aortic valve implantation vs conventional aortic valve replacement in high-risk patients with previous cardiac surgery: a propensity-score analysis†. Wilbring, Manuel; Tugtekin, Sems-Malte; Alexiou, Konstantin; Simonis, Gregor; Matschke, Klaus; Kappert, Utz // European Journal of Cardio-Thoracic Surgery;Jul2013, Vol. 44 Issue 1, p42 

    OBJECTIVES The present analysis compared clinical and mid-term outcomes of patients with previous cardiac surgery undergoing transapical transcatheter aortic valve implantation (TAVI) with propensity-matched patients undergoing conventional redo aortic valve replacement (cAVR). METHODS Since...

  • 885 Aortic dilation and dissection in patient after aortic valve replacement because of a bicuspid aortic valve Han, M.; Bouma, B.J.; De Mol, B.A.J.; Van DerWal, A.; Van Den Brink, R.B.A. // European Journal of Echocardiography;Dec2006 Supplement 1, Vol. 7, pS146 

    An abstract of the article "Aortic dilation and dissection in patient after aortic valve replacement because of a bicuspid aortic valve," by M. Han and colleagues is presented.

  • Cerebral microembolization likely in all cases of TAVI.  // Cardiology Today;Oct2012, Vol. 15 Issue 10, p48 

    The article focuses on a study which revealed that cerebral microembolization was detected in all patients who underwent transcatheter aortic valve implantation.

  • TAVI: from home-made prosthesis to global interventional phenomenon. Binder, Ronald K.; Webb, John G. // Heart;Nov 2012 Supplement, Vol. 98, piv30 

    Surgical aortic valve replacement (AVR) was first developed in the 1960s. The procedure rapidly became first-line therapy for the management of symptomatic severe aortic stenosis (AS). Concurrently, percutaneous catheter-mounted valves were evaluated in animals, although these did not make it...

  • Repair versus replacement of the aortic valve in active infective endocarditis. Mayer, Katharina; Aicher, Diana; Feldner, Susanne; Kunihara, Takashi; Schäfers, Hans-Joachim // European Journal of Cardio-Thoracic Surgery;Jul2012, Vol. 42 Issue 1, p122 

    OBJECTIVES Aortic valve repair has advantages over replacement in stable aortic regurgitation. It is unclear whether this is similar in active endocarditis. METHODS From January 2000 to July 2009, 100 patients (age 54.9 ± 15.1 years) underwent surgery for aortic valve endocarditis....

  • Cardiac surgery in patients with a porcelain aorta in the era of transcatheter valve implantation†. Urbanski, Paul P.; Raad, Mahli; Wagner, Matthias; Heinz, Nicolas; Reents, Wilko; Diegeler, Anno // European Journal of Cardio-Thoracic Surgery;Jul2013, Vol. 44 Issue 1, p48 

    OBJECTIVES New surgical and perfusion techniques allow the avoidance of deep hypothermia during open aortic arch surgery, which is generally necessary in patients with an unclampable porcelain aorta. The aim of the study was to evaluate operative and long-term results in patients with a...

  • Contemporary management of aortic stenosis: surgical aortic valve replacement remains the gold standard. Walther, Thomas; Blumenstein, Johannes; van Linden, Arnaud; Kempfert, Jörg // Heart;Nov 2012 Supplement, Vol. 98, piv23 

    Aortic valve disease is the most frequent acquired heart valve lesion in humans. In western communities, approximately 90% of patients present with aortic stenosis (AS), predominantly of a calcific degenerative aetiology. The remaining approximately 10% of patients predominantly present with...

  • The use of robotic endovascular catheters in the facilitation of transcatheter aortic valve implantation. Rippel, Radoslaw A.; Rolls, Alex E.; Riga, Celia V.; Hamady, Mohamad; Cheshire, Nicholas J.; Bicknell, Colin D. // European Journal of Cardio-Thoracic Surgery;May2014, Vol. 45 Issue 5, p836 

    OBJECTIVES The use of transcatheter aortic valve implantation (TAVI) is rapidly increasing with advances in technology and improved clinical outcomes. Adoption of robotic catheter technologies could have a role in TAVI, in different stages of the procedure, to improve endovascular tool...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics